Michiel E. Ultee, PhD, was Chief Scientific Officer at Laureate Pharma, Inc.
Implications of Cell Culture Conditions on Protein Glycosylation
The authors present a review of the techniques commonly used for glycosylation analysis.
A 25-Year Retrospective on Bioprocessing mAbs
Michiel E. Ultee of Laureate Biopharmaceutical Services gives an update on 1988 article regarding virus testing and how the advance of monoclonal antibodies has changed processes.
Developing Discoveries into New Therapeutics
Formulators and developers are at the heart of the industry's basic premise-they are saving lives.
Facilitating Technology Transfer to Your CMO
How to ensure smooth technology transfers.
Solutions for Purification of Fc-fusion Proteins
When platform processes are applied to fusion molecules, innovation and flexibility are needed.